
Canopy Growth Corporation names Sebastian Blöte as Germany country manager
Blöte starts Oct. 1 as Canopy seeks German medical cannabis growth; its June quarter international cannabis revenue was C$9.6M.

The perpetual, royalty-free agreement covers two brands, while a Texas launch still requires final state licensure and regulatory approval.

Blöte starts Oct. 1 as Canopy seeks German medical cannabis growth; its June quarter international cannabis revenue was C$9.6M.

The Sept. 25 charter amendment doubles common-share capacity and raises the cannabis landlord’s preferred-share ceiling without a shareholder vote.
Its Texas subsidiary would pay PsyLabs the milestones for the first drug candidate; the binding terms lapse without a definitive agreement by Nov. 30.
The Sept. 28 vote approved articles changes, preferred allotments and market repurchases; a possible IPO still needs an FCA-approved prospectus.

The four-year line starts at SOFR plus 175 basis points and can back utility and equipment obligations with letters of credit.

Smackover Lithium can send optional tonnes to another buyer while it seeks about US$1.1 billion of debt and an investment decision in 2026.

The Manitoba reserve plan adds two years to Snow Lake's schedule and forecasts 185,000 gold ounces a year on average through 2030.

Under current budgets, Fulcrum expects a £2.5M loan draw and £500K equity subscription to fund its pilot and first Teck-Hughes programme.
The 40-patient tipelukast study missed its week-24 liver-fat and triglyceride comparisons, although secondary HDL measures improved.
The first Cape Station block is due for contractual commercial operation by Oct. 1, while two more blocks target Jan. 1, 2027.
An unnamed AI lab committed to enter a separate ten-year Barber Lake lease after Fluidstack's term; first rent commencement is expected in the fourth quarter of 2026.
Hole TAK-26-16 includes 229 grams per tonne gold over 0.65 metre, with results from four Phase III holes pending.
The term starts when Building One is ready for service; Fermi gave no date or contract value in its Sept. 24 announcement.
The first 556,500-ounce reserve backs an 8.5-year Granite Creek plan, with Lone Tree processing scheduled for late 2027.
The Sept. 25 meeting lacked quorum, leaving shareholders until 9 a.m. EDT on Oct. 23 to submit proxies before the reconvened vote.
Gold, silver, uranium, lithium, copper and rare earths: the producers, the developers and the projects behind them.
View all
The other two Lorado holes showed no significant anomalous radioactivity; Gulch drilling is planned for 900 metres in three holes.
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
View all
A September QIAGEN safety document lists 13 bacterial targets and 18 resistance markers for the newly cleared assay.
Technology, computing, crypto and cannabis, and the listed companies moving in them.
View all
Most of the award remains unfunded as Amprius targets 12 million cells a year from a converted U.S. line by early 2028.
The AIM software group ended a process begun in March and reported £6.3 million revenue for the six months to July 31.
Uranium, lithium, oil and gas, hydrogen and the grid: the fuels and the companies behind them.
View all
OPG's Sept. 25 supplier post names ATS's tooling and a 125,000-square-foot facility addition without stating a contract value or delivery date.

SIDEX and NQ Mining Investment lead the flow-through sale, priced at C$0.145 a share and expected to close about Sept. 29.

The Czech supplier must develop an SMR prototype before global deliveries; the current award's price and shipment date were not released.
Licensed producers, retail, policy, and the psychedelics companies moving through the clinic.
View all
Holders will weigh a new parent company, a Delaware move and a voting-share sunset extension as Cresco pursues a potential U.S. listing.

The applications pair LSD, ketamine and ibogaine with N-acylethanolamines, while the scope of any patent rights remains undecided.

Curaleaf urged a signature on Sept. 23; A10698B would let regulators seek suspensions and impose daily civil penalties.

Aurora cites missing pro forma financials, a French-language notice and the mandatory 105-day deposit period in its ASC application.